; and (ii) is deemed by the Commissioner of Food and Drugs to be critical to the health and safety of United States consumers. (C) The term produce means manufactured, prepared, propagated, compounded, or processed, in whole or in part. (b) Certification concerning Chinese pharmaceutical regulation (1) In general Not later than 180 days after the date of enactment of this Act, the Commissioner of Food and Drugs (in this subsection referred to as the Commissioner ) shall certify to the Congress whether the Chinese pharmaceutical industry is being regulated for safety (including regulation of such industry by Chinese authorities and the Food and Drug Administration) to substantially the same degree as the United States pharmaceutical industry. (2) Investigations The Commissioner— (A) shall conduct such investigations as may be necessary to make the certification required by paragraph (1); and (B) in conducting such investigations, may use unannounced inspections and demand all necessary onsite access. (3) Plan If the Commissioner certifies pursuant to paragraph (1) that the Chinese pharmaceutical industry is not being regulated for safety to substantially the same degree as the United States pharmaceutical industry, the Commissioner shall, not later than 60 days after the Commissioner submits the certification required by paragraph (1), submit a plan to the Congress to protect United States consumers from unsafe Chinese drugs. (c) Purchasing plan (1) In general Not later than 90 days after the date of the enactment of this Act, the Secretary of Defense, in coordination with the Secretary of Health and Human Services and the Commissioner of Food and Drugs, shall submit to the Congress— (A) a plan to ensure that by 2024 no pharmaceutical products purchased for beneficiaries of health care from the Department of Defense or any associated program are made in part or in whole in China